<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
MICRO THERAPEUTICS, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 33-0569235
----------------------- -------------------
(State of Incorporation (IRS Employer
or Organization) Identification No.)
1062 Calle Negocio #F
San Clemente, California 92673
- ---------------------------------------- ----------------
(Address of Principal Executive Offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class Name of each exchange on which
to be so registered each class is to be registered
------------------- ------------------------------
None Not applicable
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, $.001 par value
-----------------------------
(Title of Class)
Page 1 of 3
<PAGE> 2
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. Description of Registrant's Securities to be Registered.
-------------------------------------------------------
See "Description of Capital Stock" and "Shares Eligible for
Future Sale" in the preliminary prospectus of the Registrant, incorporated by
reference from the Registration Statement on Form SB-2 of Registrant,
Registration No. 333-17345, filed with the Securities and Exchange Commission
on December 5, 1996, as amended on January 10, 1997 and January 13, 1997.
Item 2. Exhibits
--------
The following documents included as exhibits, as indicated, to
Registrant's Registration Statement on Form SB-2, Registration No. 333-17345,
filed with the Securities and Exchange Commission on December 5, 1996, as
amended on January 10, 1997 and January 13, 1997, are incorporated herein by
reference.
Form SB-2
Exhibit Description Exhibit Number
------------------- --------------
Certificate of Incorporation of the Company. 3.1
Bylaws of the Company, as currently in effect. 3.2
Specimen Certificate of Common Stock. 3.3
Warrant Agreement dated December 20, 1995 between the
Company and Comdisco, Inc. 4.1
Warrant Agreement dated May 21, 1996 between the
Company and Comdisco, Inc. 4.2
Amended and Restated Investors Rights Agreement dated
February 9, 1995, among the Company, the Investors named
therein and the Common Holders named therein, as amended
on May 17, 1996 and June 27, 1996. 10.5
1993 Incentive Stock Option, Nonqualified Stock Option and 10.6
Restricted Stock Purchase Plan.
1996 Stock Incentive Plan. 10.7
Employee Stock Purchase Plan. 10.8
Page 2 of 3
<PAGE> 3
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the Registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereto duly authorized.
MICRO THERAPEUTICS, INC.
By: /s/ George Wallace
---------------------------------
GEORGE WALLACE
President and Chief
Executive Officer
Dated: January 21, 1997
Page 3 of 3
